Search Results - Bojtine Kovacs, Sarolta

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells

    The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells by Staehle, Anne Marie, Peeken, Jan Caspar, Vladimirov, Georg, Hoeness, Mirjam Elisabeth, Bojtine Kovacs, Sarolta, Karantzelis, Nikolaos, Gruender, Albert, Koellerer, Christoph, Jutzi, Jonas Samuel, Pahl, Heike Luise, Staehle, Hans Felix

    Published in Leukemia
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations

    Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations by Jutzi, Jonas Samuel, Basu, Titiksha, Pellmann, Maximilian, Kaiser, Sandra, Steinemann, Doris, Sanders, Mathijs A., Hinai, Adil S.A., Zeilemaker, Annelieke, Bojtine Kovacs, Sarolta, Koellerer, Christoph, Ostendorp, Jenny, Aumann, Konrad, Wang, Wei, Raffoux, Emmanuel, Cassinat, Bruno, Bullinger, Lars, Schlegelberger, Brigitte, Valk, Peter J.M., Pahl, Heike Luise

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient

    Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient by Kovacs, Sarolta Bojtine, Luan, Jingting, Dold, Sandra Maria, Weis, Andreas, Pantic, Milena, Duyster, Justus, Wäsch, Ralph, Engelhardt, Monika

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Decreased level of serum NT-proCNP associates with disease severity in COVID-19

    Decreased level of serum NT-proCNP associates with disease severity in COVID-19 by Bojti, Istvan, Przewosnik, Anne-Sophie, Luxenburger, Hendrik, Hofmann, Maike, Neumann-Haefelin, Christoph, Esser, Jennifer S, Siegel, Patrick M, Maier, Alexander, Kovacs, Sarolta Bojtine, Kardos, Laszlo, Csanádi, Zoltan, Rieder, Marina, Duerschmied, Daniel, Lother, Achim, Bode, Christoph, Szabó, Gabor Tamas, Czuriga, Daniel

    Published in Respiratory research
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2 V617F mutated cells

    The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2 V617F mutated cells by Staehle, Anne Marie, Peeken, Jan Caspar, Vladimirov, Georg, Hoeness, Mirjam Elisabeth, Bojtine Kovacs, Sarolta, Karantzelis, Nikolaos, Gruender, Albert, Koellerer, Christoph, Jutzi, Jonas Samuel, Pahl, Heike Luise, Staehle, Hans Felix

    Published in Leukemia
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient

    Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient by Kovacs, Sarolta Bojtine, Luan, Jingting, Dold, Sandra Maria, Weis, Andreas, Pantic, Milena, Duyster, Justus, Wäsch, Ralph, Engelhardt, Monika

    Published in Haematologica
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: